Skip to content

Outcomes of zygomatic fractures: a cross-sectional study

Outcomes of zygomatic fractures: a cross-sectional study - ZY-PROM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57464
Enrollment
90
Registered
2025-05-08
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cheekbone fracture zygomafracture

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who sustained a zygomatic fracture and were treated at Erasmus MC from January 2008 to June 2023. - Patients aged 18 years and older at the time of the initial treatment.

Exclusion criteria

Exclusion criteria: - Subsequent facial trauma: Patients who experienced additional facial trauma after the initial zygomatic fracture, which could affect the outcomes and complicate the assessment of the initial treatment. - Solitair zygoma arch fracture: Patients who have a zygomatic arch fracture. This will nog influence the asymmetry or physical appearance.

Design outcomes

Primary

MeasureTime frame
Patient satisfaction and quality of life using: - FACE-Q: Tevredenheid over uiterlijk van gezicht - FACE-Q: Tevredenheid over resultaat - FACE-Q: Psychisch welzijn - FACE-Q: Sociaal functioneren - FACE-Q: Impact herstel kort na behandeling

Secondary

MeasureTime frame
Functional outcomes - Ocular motility - Cutaneous sensory function - Range of motion/mouthopening Symmetry - Degree of residual displacement and asymmetry in both hard and soft tissues post-treatment

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)